If approved, Orca-T would be the first allogeneic T-cell immunotherapy for the treatment of hematological malignancies including acute myeloid leukemia, acute lymphoblastic leukemia and ...
Based in the Basque country where you’re never more than spitting distance from a mountain, Orbea is an obvious pick when talking about lightweight climber’s bikes. It's worth noting that we recently ...
SEATTLE and VANCOUVER, British Columbia, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback